Skip to main content

Avar-e LS

Generic: SULFACETAMIDE SODIUM, SULFUR

Verified·Apr 23, 2026
Manufacturer
Mission
NDC
0178-0465
RxCUI
1000731
Route
TOPICAL
ICD-10 indication
L70.0

Affordability Check

How much will you actually pay for Avar-e LS?

In 30 seconds, see every legitimate way to afford Avar-e LS — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.

Check my options →

About Avar-e LS

What is this medication?

Avar-e LS is a prescription topical treatment that combines sodium sulfacetamide and sulfur to manage specific skin conditions. Sodium sulfacetamide is a sulfonamide antibiotic that works by inhibiting the growth of bacteria on the skin surface. Sulfur serves as a keratolytic agent, helping to soften and shed the outer layer of skin while absorbing excess oil. By combining these two active ingredients, the medication provides a dual approach to treating inflammation and bacterial concerns.

This medication is commonly prescribed for the topical control of acne vulgaris, acne rosacea, and seborrheic dermatitis. It helps to reduce the appearance of blemishes, redness, and scaly skin patches associated with these chronic conditions. Because it contains a sulfa-based antibiotic, it is important for individuals to disclose any history of sulfa allergies to their healthcare provider. It is generally applied to the affected areas once or several times a day as directed by a physician.

Copay & patient assistance

  • Patient Copay Amount: Not Publicly Available
  • Maximum Annual Benefit Limit: Not Publicly Available
  • Core Eligibility Restrictions: Residents of the United States; other terms and conditions apply (specific eligibility criteria not detailed in provided text)
  • RxBIN, PCN, and Group numbers: Not Publicly Available

External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.

Compare pricing elsewhere

RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.

We deep-link because transparency helps patients. None of these partners pay RxCopays.

Prescribing information

From the FDA-approved label for Avar-e LS. Official source: DailyMed (NLM) · Label effective Aug 12, 2025

Indications and usage
INDICATIONS: This product is indicated for use in the topical control of acne vulgaris, acne rosacea and seborrheic dermatitis.
Dosage and administration
DOSAGE AND ADMINISTRATION: Shake well before using. Cleanse affected areas. Apply a thin layer to the affected areas with light massaging, 1 to 3 times daily or as directed by a physician.
Contraindications
CONTRAINDICATIONS: This product is contraindicated in persons with known or suspected hypersensitivity to any of the ingredients of the product. This product is not to be used by patients with kidney disease.
Warnings
WARNINGS: Sulfonamides are known to cause Stevens-Johnson syndrome in hypersensitive individuals. Stevens-Johnson syndrome also has been reported following the use of sodium sulfacetamide topically. Cases of drug-induced systemic lupus erythematosus from topical sulfacetamide also have been reported. In one of these cases, there was a fatal outcome. KEEP OUT OF THE REACH OF CHILDREN.
Adverse reactions
ADVERSE REACTIONS: Reports of irritation and hypersensitivity to sodium sulfacetamide are uncommon. The following adverse reactions, reported after administration of sterile ophthalmic sodium sulfacetamide, are noteworthy: instances of Stevens-Johnson syndrome and instances of local hypersensitivity which progressed to a syndrome resembling systemic lupus erythematosus; in one case a fatal outcome was reported (see WARNINGS).

Label text is reproduced as-is from the FDA-approved label. We do not paraphrase, summarize, or omit. Content above is for informational purposes only and is not medical advice. Always consult your prescribing clinician or pharmacist before making decisions about your medication.

Conditions we've indexed resources for

Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.

Prior authorization & coverage

PayerPAStep therapyCopay tier

Medicare Part D

Related drugs

How this page is sourced

  • Drug identity verified against openFDA NDC Directory.
  • Label text (when shown) originates from NLM DailyMed.
  • Copay and assistance URLs verified periodically; if you hit a broken link, tell us.